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Ultrasonic hyperthermia is a method of cancer treatment in which tumors are exposed to an
elevated cytotoxic temperature using ultrasound (US). In conventional ultrasonic hyperthermia, the
ultrasound-induced heating in the tumor is achieved through the absorption of wave energy.
However, to obtain appropriate temperature in reasonable time, high US intensities, which can
have a negative impact on healthy tissues, are required. The effectiveness of US for medical pur-
poses can be significantly improved by using the so-called sonosensitizers, which can enhance the
thermal effect of US on the tissue by increasing US absorption. One possible candidate for such
sonosensitizers is magnetic nanoparticles with mean sizes of 10–300 nm, which can be efficiently
heated because of additional attenuation and scattering of US. Additionally, magnetic nanoparticles
are able to produce heat in the alternating magnetic field (magnetic hyperthermia). The synergetic
application of ultrasonic and magnetic hyperthermia can lead to a promising treatment modality.
Published by AIP Publishing. [http://dx.doi.org/10.1063/1.4955130]
Hyperthermia is a type of cancer treatment in which the
target tumor is exposed to elevated temperatures (41–46 C).1
Hyperthermia has been widely used as a medical procedure
for cancer treatment because of its simple implementation,
low cost, and reduced complication.2 Different techniques
have been used to generate thermal energy, including ultra-
sound (US). At ultrasound intensities lower than either ther-
mal ablation or tissue disintegration, slight temperature
elevations are achieved and the treatment is classified as
hyperthermia.3 Ultrasound has considerable physical advan-
tages over most techniques since the beam can be focused
strongly because of its short wavelength.4 In conventional
ultrasonic hyperthermia, the ultrasound-induced heating is
achieved by the attenuation of ultrasonic wave in the tissue
and conversion of its energy into heat. This process involves
both scattering and absorption, although it is dominated by
the latter, and indeed, the scattered wave is subsequently
absorbed.3 The therapeutic effect of ultrasound irradiation
can also be achieved through the physical destruction of cellu-
lar structures because of cavitation processes.5 However,
to obtain appropriate temperatures in reasonable time, high
ultrasound wave intensities (1–100W/cm2), which can have
a negative impact on healthy tissues,6 are required. The effec-
tiveness of ultrasounds for sonodynamic therapy can be sig-
nificantly improved by using the so-called sonosensitizers,
which can enhance the thermal effect of ultrasound on the
tissue by increasing US absorption. One possible candidate
for such sonosensitizers is nanoparticles with mean sizes
of 10–300 nm, which can be efficiently heated in aqueous
suspensions because of additional attenuation and scattering
of ultrasounds. Sviridov et al.7 have shown that aqueous
suspensions of porous silicon nanoparticles undergo signifi-
cant heating compared with pure water under therapeutic
ultrasonic (US) irradiation. Nanoparticle-induced heating
can result in a significant increase of the mean temperature
of aqueous suspensions, which is 1.5–2 times higher than
that for pure water.7 Other nanoparticles were also tested
as candidates for sonosensitizers, e.g., gold or graphene
oxide particles, which proved to exhibit good heating effi-
ciency.8 In this work, however, we focused on superparamag-
netic iron oxide nanoparticles (SPIONs) coated with a
biocompatible shell. SPIONs are a single domain and possess
a magnetic moment proportional to the volume of the particle.
Additionally, magnetic nanoparticles can have multifunctional
characteristics with complimentary roles.9 Magnetic nanopar-
ticles by themselves are able to produce localized heating of
the sample that can be fine-tuned and controlled by the alter-
nating magnetic field (AMF).10 The aforementioned types of
particles, i.e., diamagnetic gold nanoparticles, nonmagnetic
porous silicon, and graphene oxide nanoparticles, do not offer
such possibility. In a non-homogeneous alternating magnetic
field, magnetic nanoparticles oscillate mechanically and can
also generate ultrasound waves,11,12 which can be used for
magnetoacoustic imaging of diseased tissues.13 Also micro-
bubbles coated with magnetic nanoparticles can have a wide
range of biomedical applications. Under the influence of ultra-
sonic wave, such microbubbles start to vibrate and if the pres-
sure is sufficient enough, some nanoparticles can free
themselves and travel away from the bubble.14
In this work, Fe3O4 nanoparticles were prepared through
the chemical coprecipitation using ferric and ferrous salts in
alkali medium.15 The nanoparticles were coated with the sur-
factant sodium oleate (C17H33COONa) to prevent the agglom-
eration of the particles. The magnetite particles stabilized by
oleate bilayer were dispersed in water. Agglomerates were
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removed through centrifugation (9000 rpm for 30 min).
Transmission electron microscopy (TEM) images of the
prepared magnetite particle and their size histogram are
presented in Fig. 1(a). Additionally, the magnetometry meas-
urements (SQUID) were performed (Fig. 1(b)) to determine
both the particle size distribution (inset in Fig. 1(b)) and the
volume concentration of the magnetite particles in suspension,
which is 70mg/ml. The peak value of the particle size distri-
bution obtained from the SQUID corresponds to that from the
particle size distribution determined from the TEM image,
and that is around 6 nm.
The hyperthermia experiments were performed in a
tissue-mimicking phantom. Over the last decade, tissue mim-
icking phantoms have been routinely used as a powerful tool
for the performance testing of ultrasonic hyperthermia. The
gel form of agar has been widely used by researchers as a
phantom of human tissue because its acoustic characteristic
(sound speed near 1540m/s, density near 1.0 g/cm3, and
attenuation coefficient near 0.5 dB/cm/MHz) is very similar
to that of the human tissue.16
Two types of agar phantom samples were prepared for
measurements: pure agar gel without any added scattering
material and agar gel with magnetic nanoparticles. Agar
powder was dissolved in hot distilled water. During the pro-
duction process of the gel, the magnetic nanoparticle scatter-
ers were added. Samples were made by varying the weight
concentration of agar from 3% to 10% (w/v). The weight
concentrations of Fe3O4 particles were 8 and 16mg/ml.
The apparatus used for the ultrasonic hyperthermia
experiments consists of a signal generator joined to a high-
frequency power amplifier, which feeds the continuous wave
signal into a broadband power amplifier that drives the ultra-
sonic Langevin transducer. The transducer consists of two
piezoceramic rings mechanically pressed with the help of a
steel bolt as well as back (steel) and front (aluminum) vibrat-
ing masses. The front acoustic mass vibrates with an alumi-
num concentrator, the length of which corresponds to half
of the ultrasonic wave (k/2ﬃ 125mm).17 The tip of the con-
centrator is connected to the tissue-mimicking phantom. The
emitter area was 2.5 cm2. The investigation was performed
for constant ultrasound power. A schematic representation of
the experimental set-up for ultrasonic hyperthermia is shown
in Fig. 2. The temperature of the sample was monitored
using thermometer with two thermocouple sensors T1 and
T2, which were placed in the center of the ultrasonic beam—
1/3rd and 2/3rd the height of the sample from the ultrasonic
head, respectively. The measuring system allowed a continu-
ous recording of the temperature inside the sample upon its
heating by the ultrasound. Also, a visual IR thermometer that
combines surface temperature measurement and real-time
thermal and visual images was used.
Fig. 3 presents thermal images of the agar gel phantom
before and during ultrasound irradiation. Evidently, the sam-
ple is heated under the influence of ultrasound. The tempera-
ture of the phantoms increases because of the operation of
ultrasound waves generated by the transducer.
Fig. 4 presents temperature measurements in pure agar
gels and agar gels with magnetic nanoparticles with concen-
tration of 8mg/ml and 16mg/ml, respectively. The figure
shows the dependence of the temperature in the phantom on
the duration of the ultrasound treatment. The temperature
profile of agar gel with sonosensitizers (SPIONs) showed
FIG. 1. (a) TEM images with the magnetic particle size distribution and (b)
magnetization curve M(H) for the ferrofluid obtained from SQUID data and
particle magnetic core size distributions.
FIG. 2. A block diagram of the experimental set-up for ultrasonic
hyperthermia.
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higher heating rates dT/dt in comparison with pure agar gel.
In the sample without sonosensitizers, within 5 min the tem-
perature increased by 6 C, whereas for the samples with the
low and high concentration of sonosensitizers, the tempera-
ture increased by 10 C and 15.3 C, respectively. Thus, an
increase of the number of nanoparticles (within the studied
range) leads to a better heating effect.
The ultrasound heat generation is the consequence of
acoustic wave attenuation. Fig. 5(a) shows the dependence of
temperature rise in the phantoms, with and without nanopar-
ticles, on weight percentages of agar. In both samples, a
monotonic rise of temperature with the increasing agar con-
centration can be seen. The increase in ultrasonic attenuation
in pure agar gel samples can be explained by the process asso-
ciated with interactions in the junction zones or aggregates.
These interactions are apparently dominated by entropy and
volume changes.18 On the other hand, nanoparticles induce
some additional attenuation for acoustic waves that is charac-
teristic for particulate media. It depends in part on the contrast
between the physical properties of both the suspended par-
ticles and the continuous phase and also on the concentration
of solid particles, wavelengths of compression waves, and, in
certain cases, thermal wave resulting in heat flow between
the material phases.19 The heating achieved through the sono-
sensitizing properties of nanoparticles has been observed
and explained by the enhanced US attenuation in the region
near the nanoparticles. Apparently, the local temperature
near each nanoparticle can be significantly higher than the
mean one. Attenuation of ultrasonic wave (measured by the
pulse-echo technique, f¼ 5MHz) in samples with 7% concen-
tration of agar is a¼ 0.92 dB/cm without nanoparticles and
a¼ 1.46 dB/cm after the addition of sonosensitizers. Fig. 5(b)
shows the difference in temperatures measured by sensors
placed at two heights on the sample for various concentrations
of agar. A decrease in ultrasonic wave intensity and thermal
conductivity are responsible for the lower temperature rise at
the sample position further away from ultrasonic transducer
tip. For the 5% agar-gel sample, after 5min of US radiation,
FIG. 3. Pyrometer images of agar gel with magnetic nanoparticles before (a), (b) and during (c), (d) hyperthermia. The images in panels (b)–(d) were obtained
by blending visible images with the respective infrared heat maps.
FIG. 4. Hyperthermia curve obtained for agar gel (black squares) and agar
gel with magnetic nanoparticles with concentration of 8mg/ml (red circles)
and 16mg/ml (blue triangles). In both samples, the concentration of agar
was 7%.
FIG. 5. (a) Temperature change after 5 min of hyperthermia for different
concentrations of pure agar gel samples (black squares) and agar gel samples
with magnetic nanoparticles (red circles), and (b) the difference in tempera-
tures measured by sensors placed at two heights on the sample.
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the first and second thermocouple registered changes of tem-
peratures are, respectively, DT1¼ 5.1 C and DT2¼ 1.8 C
for pure agar gel sample and DT1¼ 10 C and DT2¼ 3.1 C
for the sample with nanoparticles.
Superparamagnetic iron oxide particles can also be used
as therapeutic agents for magnetic-field-induced hyperther-
mia. Magnetic nanoparticles by themselves are able to pro-
duce localized heating of the sample when exposed to the
alternating magnetic field. The heating effect of magnetic
particles is a result of an absorbing energy from the alternat-
ing magnetic field and its conversion into heat. There are
three mechanisms responsible for this effect: eddy current
losses, hysteresis losses during reversal of magnetization,
and relaxation losses accompanying demagnetization. In the
range of superparamagnetism, the major heating mechanism
of nanoparticles is relaxation. Such mechanism has two
variants. Neel’s relaxation is the flipping of the magnetic
moment within a particle by overcoming the magnetic
anisotropy energy barrier, E¼KV (K – anisotropy constant,
V – volume of nanoparticle), without the physical movement
of the whole particle. The Brown relaxation mechanism
works in a slightly different manner: it causes the rotation of
the whole particle in a viscous carrier fluid. These two mech-
anisms work in parallel. The effective relaxation time, s, is
then dominated by the faster relaxation mechanism.
The effect of magnetic hyperthermia on tissue-mimicking
phantoms was determined through calorimetric measurements
carried out in the experimental setup described earlier.20
Temperature was recorded every second using thermometer
equipped with an optical fiber sensor (within a thermocouple
temperature sensor, the AC magnetic fields can affect ther-
mometer readings by generating eddy currents, which leads to
increased temperature in the thermometer itself and its sur-
roundings20). Fig. 6 presents examples of temperature change
in agar gel and agar gel with magnetite nanoparticle samples
under the influence of AMF. The heating effect can be
observed in agar gel phantom with magnetite nanoparticles.
The rate of the temperature growth was dT/dt¼ 3.21mK/s.
This rather small value of heating rate is probably the result of
quenching of Brown relaxation mechanism due to the fixed
position of nanoparticles in agar medium. However, this can
be compensated by using bigger particles with size range
between superparamagnetism and magnetic multi-domains
(i.e., 10–100 nm) and utilizing the hysteresis loss mechanism,
which shows remarkable dependence on mean size and distri-
bution width.21 The use of bigger nanoparticles would also
increase the efficiency of ultrasonic hyperthermia. The AMF
did not influence the temperature in the sample without
nanoparticles.
These experiments have shown that magnetic nanopar-
ticles can be used as sonosensitizers for the US-induced
hyperthermia and as therapeutic agents for magnetic-field-
induced hyperthermia. Magnetic nanoparticles that have
been inserted into a tissue not only enhance the effectiveness
of ultrasonic hyperthermia because of the increased coeffi-
cient of ultrasound absorption but also become the source of
additional heating, the amount of which can be controlled by
the magnetic field. Our preliminary results shown in Fig. 7
clearly indicate that in the samples with magnetic nanopar-
ticles, the synergetic action of ultrasounds and magnetic field
allowed achieving better heating effect in comparison to the
heating by either US or AMF alone. This synergistic effect is
confirmed by specific absorption rate (SAR) values, which
describe overall heating properties of any material. The SAR
values were calculated from the formula SAR ¼ cp dTdt
 
t¼0,
where cP is the specific heat capacity of the sample and
ðdT=dtÞt¼0 is the measured initial slope of the heating curve.
The SAR values are 66 mW/g for magnetic hyperthermia,
175mW/g for ultrasonic hyperthermia, and 375mW/g for
both methods applied simultaneously.
This synergetic application of ultrasonic and magnetic
hyperthermia can lead to a promising treatment modality
with shorter time regimes, lower intensities of ultrasound,
and minimal use of magnetic material delivered to the body.
This therapy would be safer for healthy tissues because of
better controlled temperature by means of the alternating
magnetic field.
In summary, the obtained experimental results demon-
strate that magnetic nanoparticles are promising sonosensi-
tizers for ultrasound-induced hyperthermia. The presence of
magnetite nanoparticles in the tissue-mimicking phantom
increases the absorption of ultrasound energy by the sample,
FIG. 6. The recorded temperature change under the influence of the AMF
for pure agar gel (black squares) and agar gel with magnetic nanoparticles
(red circles). In both samples, the concentration of agar was 7%.
FIG. 7. Temperature change achieved through the synergetic application of
ultrasonic and magnetic hyperthermia.
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leading to increased temperature. This allows us to use lower
doses of ultrasound, that is, with a lower intensity and shorter
duration of the US treatment, and still achieve the therapeu-
tic goal. Magnetic nanoparticles can also be used for mag-
netic hyperthermia—they produce heating of the sample
when exposed to the alternating magnetic field. Thus, mag-
netic hyperthermia and ultrasonic hyperthermia may work
synergistically, rather than independently, to produce a more
efficient (faster and better controlled reaching of the thera-
peutic temperature) and safer (lower intensities of US wave
and less magnetic material) treatment with minimum side
effects.
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